10-Q: Natural Health Trends Reports Q3 Loss Amid Sales Decline

Natural Health Trends Corp. reported a net loss of $431,000 in Q3 2025, a significant drop from a $35,000 net income in the prior year, driven by an 11% decrease in net sales and ongoing challenges in its key China market.

Summary

• Net sales for the three months ended September 30, 2025, decreased by 11% to $9.5 million, down from $10.7 million in the comparable prior-year period.
• For the nine months ended September 30, 2025, net sales fell 7% to $30.0 million, compared to $32.1 million in the same period last year.
• The company reported a net loss of $431,000 for Q3 2025, a reversal from a net income of $35,000 in Q3 2024.
• For the nine-month period, a net loss of $294,000 was recorded, compared to a net income of $396,000 in the prior year.
• Basic earnings per share (EPS) for Q3 2025 was $(0.04), down from $0.00 in Q3 2024, and $(0.03) for the nine months, down from $0.03 in the prior year.
• Operating loss increased to $495,000 in Q3 2025 from $275,000 in Q3 2024, and to $1.2 million for the nine months from $878,000 in the prior year.
• Active members decreased to 28,030 as of September 30, 2025, from 30,870 at December 31, 2024, and 30,880 at September 30, 2024.
• Hong Kong net sales, primarily derived from sales to members in China, decreased by 8% in Q3 and 4% for the nine months, largely due to negative consumer sentiment from trade tariffs.
• Sales outside of Hong Kong decreased by 25% in Q3 and 15% for the nine months, mainly due to the Chinese e-commerce retail business.
• Cash, cash equivalents, and marketable securities totaled $32.0 million as of September 30, 2025, a decrease of $11.9 million from December 31, 2024.
• Net cash used in operating activities increased to $5.0 million for the first nine months of 2025, up from $3.5 million in the prior year.
• Working capital decreased by $7.1 million to $23.1 million as of September 30, 2025, from $30.2 million at December 31, 2024.
• The company paid the final installment of $5.1 million for the U.S. repatriation tax in April 2025.

Sentiment

Score: 3

Explanation: The company reported significant declines across key financial metrics including net sales, net income, and operating cash flow, coupled with a notable decrease in active members. While liquidity remains adequate, the deteriorating operational performance and ongoing geopolitical risks in its primary market present substantial headwinds.

Positives

• The company maintains a healthy current assets to current liabilities ratio of 2.6 to 1.0, indicating good short-term liquidity.
• Cash, cash equivalents, and marketable securities still total $32.0 million, providing a strong liquidity position.
• The Board of Directors declared a quarterly cash dividend of $0.20 per common share, payable on November 28, 2025, demonstrating a commitment to shareholder returns.
• A stock repurchase program with $21.9 million remaining available for future purchases is in place.
• The company is taking initial steps to transition product manufacturing from the U.S. to other Asian jurisdictions to mitigate tariff effects, potentially leading to future cost savings in logistics, freight, and manufacturing.

Negatives

• Net sales decreased by 11% for the three months and 7% for the nine months ended September 30, 2025, indicating a declining top-line performance.
• The company shifted from a net income of $35,000 in Q3 2024 to a net loss of $431,000 in Q3 2025, and from a net income of $396,000 to a net loss of $294,000 for the nine-month period.
• Operating losses increased for both the three-month and nine-month periods, reflecting deteriorating operational efficiency.
• Basic earnings per share turned negative, from $0.00 to $(0.04) in Q3 and from $0.03 to $(0.03) for the nine months.
• The active member count significantly decreased to 28,030, down from 30,870 at the end of 2024, suggesting challenges in member retention and recruitment.
• Net cash used in operating activities increased to $5.0 million for the first nine months of 2025, indicating higher cash burn from core operations.
• Working capital decreased by $7.1 million, reflecting a reduction in readily available funds for short-term obligations.
• Gross profit margin slightly declined in Q3 2025 due to the write-off of components inventory related to discontinued products.
• Commissions expense as a percentage of net sales increased for both the threeand nine-month periods, potentially impacting profitability.
• Other income, net, decreased significantly due to less interest income earned.

Risks

• Changes in government trade and economic policies, including tariffs and disputes between the U.S. and China, may negatively affect global economic conditions and business results.
• Substantial reliance on Hong Kong operations, with nearly all revenue derived from sales to members in China, makes the company vulnerable to adverse changes in either region.
• Hong Kong's evolving political and economic landscape and increasing integration with China could negatively impact business and financial performance.
• The company has experienced negative operating cash flows in recent years, and a failure to improve could materially affect the business and stock price.
• Adverse publicity related to products, ingredients, or the network marketing program could harm financial condition and operating results.
• Unfavorable economic and market conditions and an uncertain geopolitical environment pose risks to business and financial performance.
• Product concentration and a lack of revenue diversification expose the company to specific market shifts or product failures.
• Epidemics, natural disasters, terrorist attacks, or acts of war could seriously harm the business.
• High competition in the direct-selling industry could adversely affect business.
• Failure of new products to gain member and market acceptance could harm the business.
• Reliance on a limited number of independent third parties for manufacturing and supply creates supply chain risks.
• Political and economic risks associated with entering and operating in foreign markets may impede growth.
• Failure to maintain effective internal controls in accordance with the Sarbanes-Oxley Act of 2002 could negatively impact the business and stock price.
• Adverse effects from management changes or an inability to attract and retain key management, directors, and consultants.
• A continuing loss of a significant number of members is adversely affecting the business, and failure to stabilize or increase member count could further negatively impact the business.
• Improper member actions that violate laws or regulations could harm the business, despite members being independent contractors.
• An increase in compensation paid to members would reduce profitability.
• The company may be held responsible for certain taxes or assessments related to member activities, which could harm financial condition.
• Business in China is subject to complex laws and regulations, and actual or alleged violations or government actions could materially impact the business.
• Direct-selling laws and regulations may prohibit or restrict sales efforts, leading to revenue and profitability decline.
• Subject to various laws and regulations regarding privacy, data protection, and information security, with non-compliance posing risks.
• Challenges by third parties to the legality of business operations could harm the business.
• Past and potential future lawsuits, claims, and governmental proceedings could harm the business.
• Currency exchange rate fluctuations could lower revenue and net income.
• Changes in tax or duty laws and unanticipated liabilities could adversely affect net income.
• Transfer pricing regulations affect business and results of operations.
• Products and related activities are subject to extensive government regulation, potentially delaying or limiting sales.
• New regulations governing the marketing and sale of nutritional supplements could harm the business.
• Regulations governing the production and marketing of personal care products could harm the business.
• Non-compliance with good manufacturing practices could harm operations.
• Failure to comply with domestic and foreign laws and regulations governing product claims and advertising could harm the business.
• Subject to anti-bribery laws, including the U.S. Foreign Corrupt Practices Act.
• Lack of a comprehensive product liability insurance program means product liability claims could hurt the business.
• Inability to protect or use intellectual property rights.
• Reliance on information technology systems and risks associated with system disruptions, failures, cybersecurity, and data compromises.
• Systems, software, and data residing on third-party servers expose the company to risks of disruption or intrusion.
• Common stock is particularly subject to volatility due to the industry and markets.
• Wide fluctuations in trading volumes and prices of common stock may make it difficult for holders to sell shares.

Future Outlook

The company expects to satisfy its remaining performance obligations for deferred revenue within the next twelve months. It plans to reapply for a direct selling license in China when conditions are favorable, anticipating incremental benefits but acknowledging potential offsets from higher fixed costs. The company may impose surcharges on products sold into China due to tariffs, which could further impact sales. Initial steps are being taken to transition product manufacturing from the U.S. to other Asian jurisdictions to mitigate tariff effects, though this may incur short-term expenses. The impact of trade policy changes on future quarters remains uncertain. Management believes existing internal liquidity is adequate for foreseeable operations and financial commitments, and does not currently anticipate needing to raise capital from markets.

Management Comments

• Our priority is to focus our resources in our most promising markets, which we consider to be Greater China and countries where our existing members have the connections to recruit prospects and sell our products, such as Southeast Asia, India, South America and Europe.
• We believe that neither of these activities [Hong Kong e-commerce direct selling platform and China e-commerce retail platform] require a direct selling license in China, which we do not currently hold.
• We expect to reapply for a direct selling license in China when we believe that circumstances are again ripe for doing so.
• If we are ultimately able to obtain a direct selling license in China, we believe that the incentives inherent in the direct selling model in China would incrementally benefit our existing business.
• We do not expect that any increased sales in China derived from obtaining a direct selling license would initially be material and, in any event may be partially offset by the higher fixed costs associated with the establishment and maintenance of required service centers, branch offices, manufacturing facilities, certification programs and other legal requirements.
• We are unable to predict whether and when we will be successful in obtaining a direct selling license to operate in China, and if we are successful, when we will be permitted to conduct direct selling operations and whether such operations would be profitable.
• While our first quarter 2025 financial results were not materially affected by these developments [tariffs], our second and third quarter sales were negatively affected by negative consumer sentiment and economic uncertainty in our largest market.
• In the longer term, we have taken initial steps to transition production of certain of our products currently manufactured in the United States to other jurisdictions, including in Asia, in order to mitigate the effect of U.S. and reciprocal tariffs.
• We believe that our existing internal liquidity, supported by cash on hand and cash flows from operations, should be adequate to fund normal business operations and address our financial commitments for the foreseeable future.
• We do not have any significant unused sources of liquid assets. If necessary, we may attempt to generate more funding from the capital markets, but currently we do not believe that will be necessary.

Industry Context

Natural Health Trends Corp. operates in the direct-selling and e-commerce sectors, focusing on personal care, wellness, and quality of life products. The company's business model is heavily concentrated in the Greater China market, making it particularly susceptible to geopolitical tensions and trade policy changes between the U.S. and China, such as tariffs. The direct-selling industry in China also faces a challenging regulatory environment and negative social media sentiment, which has impacted the company's sales and member recruitment. The company's strategy to diversify manufacturing locations reflects a broader industry trend of supply chain resilience in response to global trade uncertainties.

Related Party Transactions

• The company has a Royalty Agreement and License with Broady Health Sciences, L.L.C. (BHS) for the product ReStor. George K. Broady, a former director and beneficial owner of more than 5% of the company's common stock, is an indirect owner of BHS. Lucy Nduati, a current director, serves other Broady-controlled companies.
• Royalty payments to BHS were $9,000 for the three months ended September 30, 2025, and $27,000 for the nine months ended September 30, 2025.
• The agreement automatically renewed for an additional one-year term from March 31, 2025, as neither party provided the required 90-day advance notice.

Stakeholder Impact

• Shareholders are negatively impacted by declining revenue, a shift to net losses, negative EPS, and a decrease in overall liquidity and working capital. The continuation of dividends provides some return, but future payments are discretionary.
• Employees may be affected by the relocation of corporate headquarters from Hong Kong to California and lower employee-related expenses contributing to reduced SG&A.
• Customers and members are experiencing negative consumer sentiment in China due to trade policies, which has impacted sales. The decrease in active members suggests challenges in the direct-selling network.
• Suppliers may see shifts in manufacturing orders as the company explores transitioning production from the U.S. to other Asian jurisdictions.
• Creditors benefit from a healthy current ratio of 2.6 to 1.0, indicating the company's ability to meet short-term obligations, despite overall declining financial performance.

Next Steps

• Satisfy remaining performance obligations for deferred revenue within the next twelve months.
• Reapply for a direct selling license in China when circumstances are deemed 'ripe'.
• Continue investing in the Mainland China entity for establishing manufacturing capabilities, increasing brand awareness, sourcing Chinese-made products, building service stations, opening Healthy Lifestyle Centers or branch offices, and adding local staffing.
• Actively evaluate options and the impact of trade policy changes on future quarters.
• Transition production of certain products currently manufactured in the United States to other jurisdictions, including in Asia, to mitigate the effect of U.S. and reciprocal tariffs.
• The Board of Directors will continue to exercise sole discretion over the declaration and payment of any future dividends.
• The quantitative impact of the One Big Beautiful Bill Act (OBBBA) tax law changes will be reflected in the annual report on Form 10-K for the year ending December 31, 2025.

Key Dates

Recommendation

The company's latest quarterly report reveals a concerning trend of declining financial performance, marked by an 11% drop in net sales, a shift from net income to a net loss, and negative earnings per share. The active member base is shrinking, and operating cash flow has worsened. The heavy reliance on the Greater China market, which is currently facing significant headwinds from U.S.-China trade tensions and negative consumer sentiment, poses substantial ongoing risk. While the company maintains adequate liquidity, the fundamental business metrics are deteriorating, and the outlook for its key market remains highly uncertain. These factors suggest a challenging period ahead, making the stock a 'sell' for investors seeking growth and stability.

Keywords

Direct Selling, E-commerce, Health and Wellness, Personal Care, China Market, Hong Kong Operations, Tariffs, Trade Policy, SEC 10-Q, Financial Results, Net Sales, Net Loss, Operating Cash Flow, Active Members, NHTC